Evaluation of the long-term effectiveness of extraluminal and intraluminal vasodilators in an in vitro porcine model of arterial graft spasm

OBJECTIVE: Postoperative graft spasm is a concern when arterial conduitsare used because there may be insufficient arterial graft flow.Intraoperatively, vasodilators are used to increase flow and prevent spasm,but little is known about their duration of effectiveness. METHODS: Toexamine this we atta...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of cardio-thoracic surgery 1996, Vol.10 (12), p.1071-1081
Hauptverfasser: Montgomery, W D, Spence, P, Ali, A T, Ballen, J L, Riordan, C J, Storey, J H, Santamore, W P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1081
container_issue 12
container_start_page 1071
container_title European journal of cardio-thoracic surgery
container_volume 10
creator Montgomery, W D
Spence, P
Ali, A T
Ballen, J L
Riordan, C J
Storey, J H
Santamore, W P
description OBJECTIVE: Postoperative graft spasm is a concern when arterial conduitsare used because there may be insufficient arterial graft flow.Intraoperatively, vasodilators are used to increase flow and prevent spasm,but little is known about their duration of effectiveness. METHODS: Toexamine this we attached porcine gastroepiploic and internal thoracicarteries (GEA, n = 48; ITA, n = 24, 10-12 cm long) to a computer-controlledperfusion system (constant inflow pressure 80 mm Hg) with a fixed outflowresistance. Norepinephrine (10(-9)-10(-5) M) was incrementally added to theperfusate at baseline (B), then immediately (h+0) and 2 h (h+2) after thevessels were treated with 30 min of extraluminal or intraluminalnitroglycerin, nitroprusside, verapamil or papaverine. RESULTS: At (B),norepinephrine caused a dose-dependent decrease in flow in both the ITAsand GEAs. In the ITAs, at (h+0), both extraluminal and intraluminalpapaverine and, to a lesser extent nitroprusside, increased initial flowand decreased graft sensitivity to norepinephrine. At (h+2), onlyextraluminal papaverine sustained this maximal effect (ED50 forextraluminal papaverine at (B) 2.6 E(-7) vs. (h+2) 1.3 E(-6), P = 0.01).For the GEAs, at (h+0), both extraluminal and intraluminal verapamil,papaverine, nitroprusside and nitroglycerin attenuated flow reduction dueto norepinephrine. At (h+2), only extraluminal papaverine, extraluminalverapamil and intraluminal verapamil were effective in preventingnorepinephrine-induced spasm (ED50 for extraluminal papaverine at (B) 1.0E(-7) vs. (h+2) 6.4 E(-6) (P = 0.004); extraluminal verapamil at (B) 1.2E(-7) vs. (h+2) 4.0 E(- 6); intraluminal verapamil at (B) 5.8 E(-7) vs.(h+2) 5.7 E(-6), P = 0.005). CONCLUSION: Verapamil-and papaverine-treatedarteries have a greater duration of efficacy in resisting spasm thanarteries treated with nitroglycerin and nitroprusside. In the ITA,extraluminal administration of papaverine is most efficacious, possibly dueto the prolonged exposure afforded by this route of administration. Theeffects of verapamil and papaverine are more prolonged in the GEA whenadministered extraluminally, potentially due to absorption in theperivascular fat-pad and subsequent slow release. The results of this studysuggest that extraluminally administered verapamil and papaverine appear tobe the preferred vasodilators for preventing arterial graft spasm in thepostoperative period. This may be especially important when multiplearterial grafts are used.
doi_str_mv 10.1016/S1010-7940(96)80354-X
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78769094</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1016/S1010-7940(96)80354-X</oup_id><sourcerecordid>78769094</sourcerecordid><originalsourceid>FETCH-LOGICAL-c383x-9245c0c259dc31f8592647cfe17d446f073b3fde24b1936c15f09e87a82b80883</originalsourceid><addsrcrecordid>eNptkc1u1TAQhSMEoqXwCKCsECwMduz4Z4lKf4BKLArSFRvL1xkXQxKntnN1-w48NE5TUJHYjK2Z75yR5lTVc4LfEEz428tSMRKK4VeKv5aYtgxtHlSHRAqKBGWbh-X_BzmonqT0A2PMaSMeVwcEU644aw6rXyc7088m-zDWwdX5O9R9GK9QhjjU4BzY7HcwQkrLGPY5Fnzwo-lrM3a1H-81diaFzvcmh5jKpABL3fkcQz2FaP0I9RA66BcrE8sKX1RX0bhcp8mk4Wn1yJk-wbO796j6enry5fgcXXw--3D87gJZKukeqYa1FtumVZ2lxMlWNZwJ64CIjjHusKBb6jpo2JYoyi1pHVYghZHNVmIp6VH1cvWdYrieIWU9-GSh780IYU5aSMEVVqyA7QraGFKK4PQU_WDijSZYLzHo2xj0cmOtuL6NQW-K7sXdgnk7QHdPtd69AHgFwjz93xP944kWT7RKfMqw_ysy8afmgopWn2--Fenp5cdP76Um9Dco6qMs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78769094</pqid></control><display><type>article</type><title>Evaluation of the long-term effectiveness of extraluminal and intraluminal vasodilators in an in vitro porcine model of arterial graft spasm</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Montgomery, W D ; Spence, P ; Ali, A T ; Ballen, J L ; Riordan, C J ; Storey, J H ; Santamore, W P</creator><creatorcontrib>Montgomery, W D ; Spence, P ; Ali, A T ; Ballen, J L ; Riordan, C J ; Storey, J H ; Santamore, W P</creatorcontrib><description>OBJECTIVE: Postoperative graft spasm is a concern when arterial conduitsare used because there may be insufficient arterial graft flow.Intraoperatively, vasodilators are used to increase flow and prevent spasm,but little is known about their duration of effectiveness. METHODS: Toexamine this we attached porcine gastroepiploic and internal thoracicarteries (GEA, n = 48; ITA, n = 24, 10-12 cm long) to a computer-controlledperfusion system (constant inflow pressure 80 mm Hg) with a fixed outflowresistance. Norepinephrine (10(-9)-10(-5) M) was incrementally added to theperfusate at baseline (B), then immediately (h+0) and 2 h (h+2) after thevessels were treated with 30 min of extraluminal or intraluminalnitroglycerin, nitroprusside, verapamil or papaverine. RESULTS: At (B),norepinephrine caused a dose-dependent decrease in flow in both the ITAsand GEAs. In the ITAs, at (h+0), both extraluminal and intraluminalpapaverine and, to a lesser extent nitroprusside, increased initial flowand decreased graft sensitivity to norepinephrine. At (h+2), onlyextraluminal papaverine sustained this maximal effect (ED50 forextraluminal papaverine at (B) 2.6 E(-7) vs. (h+2) 1.3 E(-6), P = 0.01).For the GEAs, at (h+0), both extraluminal and intraluminal verapamil,papaverine, nitroprusside and nitroglycerin attenuated flow reduction dueto norepinephrine. At (h+2), only extraluminal papaverine, extraluminalverapamil and intraluminal verapamil were effective in preventingnorepinephrine-induced spasm (ED50 for extraluminal papaverine at (B) 1.0E(-7) vs. (h+2) 6.4 E(-6) (P = 0.004); extraluminal verapamil at (B) 1.2E(-7) vs. (h+2) 4.0 E(- 6); intraluminal verapamil at (B) 5.8 E(-7) vs.(h+2) 5.7 E(-6), P = 0.005). CONCLUSION: Verapamil-and papaverine-treatedarteries have a greater duration of efficacy in resisting spasm thanarteries treated with nitroglycerin and nitroprusside. In the ITA,extraluminal administration of papaverine is most efficacious, possibly dueto the prolonged exposure afforded by this route of administration. Theeffects of verapamil and papaverine are more prolonged in the GEA whenadministered extraluminally, potentially due to absorption in theperivascular fat-pad and subsequent slow release. The results of this studysuggest that extraluminally administered verapamil and papaverine appear tobe the preferred vasodilators for preventing arterial graft spasm in thepostoperative period. This may be especially important when multiplearterial grafts are used.</description><identifier>ISSN: 1010-7940</identifier><identifier>EISSN: 1873-734X</identifier><identifier>DOI: 10.1016/S1010-7940(96)80354-X</identifier><identifier>PMID: 10369642</identifier><language>eng</language><publisher>Germany: Elsevier Science B.V</publisher><subject>Animals ; Blood Flow Velocity - drug effects ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Drug Administration Routes ; Graft Occlusion, Vascular - physiopathology ; Graft Occlusion, Vascular - prevention &amp; control ; In Vitro Techniques ; Mammary Arteries - drug effects ; Mammary Arteries - physiopathology ; Norepinephrine - administration &amp; dosage ; Perfusion ; Postoperative Complications ; Swine ; Vasoconstrictor Agents - administration &amp; dosage ; Vasodilation - drug effects ; Vasodilator Agents - administration &amp; dosage</subject><ispartof>European journal of cardio-thoracic surgery, 1996, Vol.10 (12), p.1071-1081</ispartof><rights>Springer-Verlag 1996 1996</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c383x-9245c0c259dc31f8592647cfe17d446f073b3fde24b1936c15f09e87a82b80883</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4009,27902,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10369642$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Montgomery, W D</creatorcontrib><creatorcontrib>Spence, P</creatorcontrib><creatorcontrib>Ali, A T</creatorcontrib><creatorcontrib>Ballen, J L</creatorcontrib><creatorcontrib>Riordan, C J</creatorcontrib><creatorcontrib>Storey, J H</creatorcontrib><creatorcontrib>Santamore, W P</creatorcontrib><title>Evaluation of the long-term effectiveness of extraluminal and intraluminal vasodilators in an in vitro porcine model of arterial graft spasm</title><title>European journal of cardio-thoracic surgery</title><addtitle>Eur J Cardiothorac Surg</addtitle><addtitle>Eur J Cardiothorac Surg</addtitle><description>OBJECTIVE: Postoperative graft spasm is a concern when arterial conduitsare used because there may be insufficient arterial graft flow.Intraoperatively, vasodilators are used to increase flow and prevent spasm,but little is known about their duration of effectiveness. METHODS: Toexamine this we attached porcine gastroepiploic and internal thoracicarteries (GEA, n = 48; ITA, n = 24, 10-12 cm long) to a computer-controlledperfusion system (constant inflow pressure 80 mm Hg) with a fixed outflowresistance. Norepinephrine (10(-9)-10(-5) M) was incrementally added to theperfusate at baseline (B), then immediately (h+0) and 2 h (h+2) after thevessels were treated with 30 min of extraluminal or intraluminalnitroglycerin, nitroprusside, verapamil or papaverine. RESULTS: At (B),norepinephrine caused a dose-dependent decrease in flow in both the ITAsand GEAs. In the ITAs, at (h+0), both extraluminal and intraluminalpapaverine and, to a lesser extent nitroprusside, increased initial flowand decreased graft sensitivity to norepinephrine. At (h+2), onlyextraluminal papaverine sustained this maximal effect (ED50 forextraluminal papaverine at (B) 2.6 E(-7) vs. (h+2) 1.3 E(-6), P = 0.01).For the GEAs, at (h+0), both extraluminal and intraluminal verapamil,papaverine, nitroprusside and nitroglycerin attenuated flow reduction dueto norepinephrine. At (h+2), only extraluminal papaverine, extraluminalverapamil and intraluminal verapamil were effective in preventingnorepinephrine-induced spasm (ED50 for extraluminal papaverine at (B) 1.0E(-7) vs. (h+2) 6.4 E(-6) (P = 0.004); extraluminal verapamil at (B) 1.2E(-7) vs. (h+2) 4.0 E(- 6); intraluminal verapamil at (B) 5.8 E(-7) vs.(h+2) 5.7 E(-6), P = 0.005). CONCLUSION: Verapamil-and papaverine-treatedarteries have a greater duration of efficacy in resisting spasm thanarteries treated with nitroglycerin and nitroprusside. In the ITA,extraluminal administration of papaverine is most efficacious, possibly dueto the prolonged exposure afforded by this route of administration. Theeffects of verapamil and papaverine are more prolonged in the GEA whenadministered extraluminally, potentially due to absorption in theperivascular fat-pad and subsequent slow release. The results of this studysuggest that extraluminally administered verapamil and papaverine appear tobe the preferred vasodilators for preventing arterial graft spasm in thepostoperative period. This may be especially important when multiplearterial grafts are used.</description><subject>Animals</subject><subject>Blood Flow Velocity - drug effects</subject><subject>Disease Models, Animal</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Administration Routes</subject><subject>Graft Occlusion, Vascular - physiopathology</subject><subject>Graft Occlusion, Vascular - prevention &amp; control</subject><subject>In Vitro Techniques</subject><subject>Mammary Arteries - drug effects</subject><subject>Mammary Arteries - physiopathology</subject><subject>Norepinephrine - administration &amp; dosage</subject><subject>Perfusion</subject><subject>Postoperative Complications</subject><subject>Swine</subject><subject>Vasoconstrictor Agents - administration &amp; dosage</subject><subject>Vasodilation - drug effects</subject><subject>Vasodilator Agents - administration &amp; dosage</subject><issn>1010-7940</issn><issn>1873-734X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkc1u1TAQhSMEoqXwCKCsECwMduz4Z4lKf4BKLArSFRvL1xkXQxKntnN1-w48NE5TUJHYjK2Z75yR5lTVc4LfEEz428tSMRKK4VeKv5aYtgxtHlSHRAqKBGWbh-X_BzmonqT0A2PMaSMeVwcEU644aw6rXyc7088m-zDWwdX5O9R9GK9QhjjU4BzY7HcwQkrLGPY5Fnzwo-lrM3a1H-81diaFzvcmh5jKpABL3fkcQz2FaP0I9RA66BcrE8sKX1RX0bhcp8mk4Wn1yJk-wbO796j6enry5fgcXXw--3D87gJZKukeqYa1FtumVZ2lxMlWNZwJ64CIjjHusKBb6jpo2JYoyi1pHVYghZHNVmIp6VH1cvWdYrieIWU9-GSh780IYU5aSMEVVqyA7QraGFKK4PQU_WDijSZYLzHo2xj0cmOtuL6NQW-K7sXdgnk7QHdPtd69AHgFwjz93xP944kWT7RKfMqw_ysy8afmgopWn2--Fenp5cdP76Um9Dco6qMs</recordid><startdate>1996</startdate><enddate>1996</enddate><creator>Montgomery, W D</creator><creator>Spence, P</creator><creator>Ali, A T</creator><creator>Ballen, J L</creator><creator>Riordan, C J</creator><creator>Storey, J H</creator><creator>Santamore, W P</creator><general>Elsevier Science B.V</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1996</creationdate><title>Evaluation of the long-term effectiveness of extraluminal and intraluminal vasodilators in an in vitro porcine model of arterial graft spasm</title><author>Montgomery, W D ; Spence, P ; Ali, A T ; Ballen, J L ; Riordan, C J ; Storey, J H ; Santamore, W P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c383x-9245c0c259dc31f8592647cfe17d446f073b3fde24b1936c15f09e87a82b80883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Animals</topic><topic>Blood Flow Velocity - drug effects</topic><topic>Disease Models, Animal</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Administration Routes</topic><topic>Graft Occlusion, Vascular - physiopathology</topic><topic>Graft Occlusion, Vascular - prevention &amp; control</topic><topic>In Vitro Techniques</topic><topic>Mammary Arteries - drug effects</topic><topic>Mammary Arteries - physiopathology</topic><topic>Norepinephrine - administration &amp; dosage</topic><topic>Perfusion</topic><topic>Postoperative Complications</topic><topic>Swine</topic><topic>Vasoconstrictor Agents - administration &amp; dosage</topic><topic>Vasodilation - drug effects</topic><topic>Vasodilator Agents - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Montgomery, W D</creatorcontrib><creatorcontrib>Spence, P</creatorcontrib><creatorcontrib>Ali, A T</creatorcontrib><creatorcontrib>Ballen, J L</creatorcontrib><creatorcontrib>Riordan, C J</creatorcontrib><creatorcontrib>Storey, J H</creatorcontrib><creatorcontrib>Santamore, W P</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cardio-thoracic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Montgomery, W D</au><au>Spence, P</au><au>Ali, A T</au><au>Ballen, J L</au><au>Riordan, C J</au><au>Storey, J H</au><au>Santamore, W P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of the long-term effectiveness of extraluminal and intraluminal vasodilators in an in vitro porcine model of arterial graft spasm</atitle><jtitle>European journal of cardio-thoracic surgery</jtitle><stitle>Eur J Cardiothorac Surg</stitle><addtitle>Eur J Cardiothorac Surg</addtitle><date>1996</date><risdate>1996</risdate><volume>10</volume><issue>12</issue><spage>1071</spage><epage>1081</epage><pages>1071-1081</pages><issn>1010-7940</issn><eissn>1873-734X</eissn><abstract>OBJECTIVE: Postoperative graft spasm is a concern when arterial conduitsare used because there may be insufficient arterial graft flow.Intraoperatively, vasodilators are used to increase flow and prevent spasm,but little is known about their duration of effectiveness. METHODS: Toexamine this we attached porcine gastroepiploic and internal thoracicarteries (GEA, n = 48; ITA, n = 24, 10-12 cm long) to a computer-controlledperfusion system (constant inflow pressure 80 mm Hg) with a fixed outflowresistance. Norepinephrine (10(-9)-10(-5) M) was incrementally added to theperfusate at baseline (B), then immediately (h+0) and 2 h (h+2) after thevessels were treated with 30 min of extraluminal or intraluminalnitroglycerin, nitroprusside, verapamil or papaverine. RESULTS: At (B),norepinephrine caused a dose-dependent decrease in flow in both the ITAsand GEAs. In the ITAs, at (h+0), both extraluminal and intraluminalpapaverine and, to a lesser extent nitroprusside, increased initial flowand decreased graft sensitivity to norepinephrine. At (h+2), onlyextraluminal papaverine sustained this maximal effect (ED50 forextraluminal papaverine at (B) 2.6 E(-7) vs. (h+2) 1.3 E(-6), P = 0.01).For the GEAs, at (h+0), both extraluminal and intraluminal verapamil,papaverine, nitroprusside and nitroglycerin attenuated flow reduction dueto norepinephrine. At (h+2), only extraluminal papaverine, extraluminalverapamil and intraluminal verapamil were effective in preventingnorepinephrine-induced spasm (ED50 for extraluminal papaverine at (B) 1.0E(-7) vs. (h+2) 6.4 E(-6) (P = 0.004); extraluminal verapamil at (B) 1.2E(-7) vs. (h+2) 4.0 E(- 6); intraluminal verapamil at (B) 5.8 E(-7) vs.(h+2) 5.7 E(-6), P = 0.005). CONCLUSION: Verapamil-and papaverine-treatedarteries have a greater duration of efficacy in resisting spasm thanarteries treated with nitroglycerin and nitroprusside. In the ITA,extraluminal administration of papaverine is most efficacious, possibly dueto the prolonged exposure afforded by this route of administration. Theeffects of verapamil and papaverine are more prolonged in the GEA whenadministered extraluminally, potentially due to absorption in theperivascular fat-pad and subsequent slow release. The results of this studysuggest that extraluminally administered verapamil and papaverine appear tobe the preferred vasodilators for preventing arterial graft spasm in thepostoperative period. This may be especially important when multiplearterial grafts are used.</abstract><cop>Germany</cop><pub>Elsevier Science B.V</pub><pmid>10369642</pmid><doi>10.1016/S1010-7940(96)80354-X</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1010-7940
ispartof European journal of cardio-thoracic surgery, 1996, Vol.10 (12), p.1071-1081
issn 1010-7940
1873-734X
language eng
recordid cdi_proquest_miscellaneous_78769094
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current)
subjects Animals
Blood Flow Velocity - drug effects
Disease Models, Animal
Dose-Response Relationship, Drug
Drug Administration Routes
Graft Occlusion, Vascular - physiopathology
Graft Occlusion, Vascular - prevention & control
In Vitro Techniques
Mammary Arteries - drug effects
Mammary Arteries - physiopathology
Norepinephrine - administration & dosage
Perfusion
Postoperative Complications
Swine
Vasoconstrictor Agents - administration & dosage
Vasodilation - drug effects
Vasodilator Agents - administration & dosage
title Evaluation of the long-term effectiveness of extraluminal and intraluminal vasodilators in an in vitro porcine model of arterial graft spasm
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T08%3A37%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20the%20long-term%20effectiveness%20of%20extraluminal%20and%20intraluminal%20vasodilators%20in%20an%20in%20vitro%20porcine%20model%20of%20arterial%20graft%20spasm&rft.jtitle=European%20journal%20of%20cardio-thoracic%20surgery&rft.au=Montgomery,%20W%20D&rft.date=1996&rft.volume=10&rft.issue=12&rft.spage=1071&rft.epage=1081&rft.pages=1071-1081&rft.issn=1010-7940&rft.eissn=1873-734X&rft_id=info:doi/10.1016/S1010-7940(96)80354-X&rft_dat=%3Cproquest_cross%3E78769094%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78769094&rft_id=info:pmid/10369642&rft_oup_id=10.1016/S1010-7940(96)80354-X&rfr_iscdi=true